Heramed Ltd · ASX:HMD
Heramed — Investor Presentation (July 2019)
15 slides from Heramed's investor presentation, Jul 22, 2019
Slide 1: HeraCARE Presentation | July 2019
HeraCARE Presentation | July 2019 i yr Bal NY HeraCAkE: Cc ne) 5 E So © m © = Oo iS = 1S coms ore Do 7S) (on Om £0 D = a 5 mo)
Slide 2: Disclaimer
Disclaimer .cument contin o gener | summary of the company and is provided for information purposes only. For full details please re | 26 295 314 [HeraMED) - hips: / Awww.asx.com.au/asxpdl/2018 1210/pd/44 | 3gcs992kjsx. | lctaion or recommen ec! to the purchase or sale of any security in HetaMED nor
Slide 3: Leading The Digital Transformation of Pregnancy
Leading The Digital Transformation of Pregnancy The Most Advanced, Smart, Medical Grade, Home Pregnancy Management Platform Improving Mother & Baby Wellness Empowering Personalized, Proactive Care ' . We ae Reshaping Doctor/ Patient Relationship E TT iA” _. Providing Better Care at Lower Cost
Slide 4: HeraCARE Platform
HeraCARE Platform IP Comprehensive solution leveraging existing infrastructure and devices Customisable care Manager Platform Customisable Hera app oo Blood Pressure EL © Powered by ORION Communication Data driven dashboard for medical professionals Foetal Heart Rate HERA @ from the HeraBEAT device
Slide 5: HeraCARE - Highlights
HeraCARE - Highlights A new pregnancy care approach | digital | connected | home based Based on empowerment, education & selfmeasurement Fully customizable to local prenatal care standards Seamlessly integrated into IT infrastructure of healthcare organisations Optimized adherence to prenatal care g
Slide 6: For personal use only
For personal use only • • • • • • • • • • • • • • • • • • 6
Slide 7: HeraCARE - Key Targeted Outcomes
HeraCARE - Key Targeted Outcomes offered through Insurers and employers to achieve the triple aim: @) -~ Gs Reduced Cost Increased Satisfaction Cost reductions achieved Increase pregnant Favorable clinical outcomes through reducing employee satisfaction from achieved through reduction of unscheduled
Slide 8: For personal use only
For personal use only • • • • • • 8
Slide 9: For personal use only
For personal use only • • • • • • • • • • • 9
Slide 10: Scalable Recurring Pricing Model
Scalable Recurring Pricing Model LICENSE STANDARD fee Free Features Task Based Prenatal Care Included Included Included Social Support Network Basic Basic Enhanced <i Patient Education Basic Basic Personalized a F Working Hours 24/7 Qo Midwife consultancy I Soria Message based, Email Hot line/ Chat/
Slide 11: For personal use only
Personal use only Sy HERA @ MED David Groberman CEO & Co-founder Mobile +972-52-699 1188 David@Hera-Med.com HeraMED Lid.
Slide 12: For personal use only
For personal use only $0.29 $0.27 $0.25 $0.23 $0.21 $0.19 $0.17 $0.15 12
Slide 13: Appendix 2: Board of Directors
HERA @ "] MED @@ | Appendix 2: Board of Directors Dr. Ron Weinberger — Non-Executive Chairman Highly experienced business executive, with strong scientific background and international span| Ex president and CEO of Nanosonics Lid. ASX: NAN, Mkt cap ~$AUD 1.35 Billion David Groberman — CEO, Co-Founde
Slide 14: Vinod Khosla – billionaire investor
For personal use only Vinod Khosla – billionaire investor 14
Slide 15: Appendix 4: Distribution Network
| Appendix 4: Distribution NEtWOFk @ enwssii irs hy eee k = = =@ Near ten markets entries Considerable progress made to date ? al / : in expanding HMD’s distribution ad ee ( es f re network. C - ae 7 f ¢ HeraMED has secured distribution agreements in 5 countries. Discussions with medical organisatio